Bayer's Xarelto gets China FDA nod for stroke prevention; Guangzhou Baiyunshan gets Q1 lift on Viagra generic;

> Bayer's Xarelto was approved in China for stroke prevention in patients with non-valvular atrial fibrillation and deep vein thrombosis. Release

> Hong Kong-listed Guangzhou Baiyunshan Pharmaceutical's net profit rose nearly 15% in the first quarter aided by its approval last year from China's State Food and Drug Administration to produce a generic version of Viagra. Release (PDF)